These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12407509)

  • 1. Biochemotherapy of melanoma.
    Flaherty LE; Gadgeel SM
    Semin Oncol; 2002 Oct; 29(5):446-55. PubMed ID: 12407509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale for intergroup trial E-3695 comparing concurrent biochemotherapy with cisplatin, vinblastine, and DTIC alone in patients with metastatic melanoma.
    Flaherty LE
    Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S15-20. PubMed ID: 10685653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemotherapy for advanced melanoma.
    Keilholz U; Gore ME
    Semin Oncol; 2002 Oct; 29(5):456-61. PubMed ID: 12407510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemotherapy of melanoma.
    Keilholz U
    Forum (Genova); 2003; 13(2):158-65; quiz 189. PubMed ID: 14732882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential biochemotherapy versus chemotherapy for metastatic melanoma: results from a phase III randomized trial.
    Eton O; Legha SS; Bedikian AY; Lee JJ; Buzaid AC; Hodges C; Ring SE; Papadopoulos NE; Plager C; East MJ; Zhan F; Benjamin RS
    J Clin Oncol; 2002 Apr; 20(8):2045-52. PubMed ID: 11956264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined chemoimmunotherapy in metastatic melanoma--is there a need for the double?
    Schrader AJ
    Anticancer Drugs; 2000 Mar; 11(3):143-8. PubMed ID: 10831272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II multicenter trial of maintenance biotherapy after induction concurrent Biochemotherapy for patients with metastatic melanoma.
    O'Day SJ; Atkins MB; Boasberg P; Wang HJ; Thompson JA; Anderson CM; Gonzalez R; Lutzky J; Amatruda T; Hersh EM; Weber JS
    J Clin Oncol; 2009 Dec; 27(36):6207-12. PubMed ID: 19917850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of chemotherapy with interleukin-2 and interferon-alfa for the treatment of advanced melanoma.
    Buzaid AC; Legha SS
    Semin Oncol; 1994 Dec; 21(6 Suppl 14):23-8. PubMed ID: 7992096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemotherapy for melanoma.
    Philip PA; Flaherty LE
    Curr Oncol Rep; 2000 Jul; 2(4):314-21. PubMed ID: 11122859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and results of biochemotherapy in metastatic melanoma: the University of Texas M.D. Anderson Cancer Center experience.
    Legha SS; Ring S; Eton O; Bedikian A; Plager C; Papadopoulos N
    Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S9-15. PubMed ID: 9457387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy compared with biochemotherapy for the treatment of metastatic melanoma: a meta-analysis of 18 trials involving 2,621 patients.
    Ives NJ; Stowe RL; Lorigan P; Wheatley K
    J Clin Oncol; 2007 Dec; 25(34):5426-34. PubMed ID: 18048825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide and neopterin levels and clinical response in stage III melanoma patients receiving concurrent biochemotherapy.
    Anderson CM; Buzaid AC; Sussman J; Lee JJ; Ali-Osman F; Braunschweiger PG; Plager C; Bedikian A; Papadopoulos N; Eton O; Legha SS; Grimm EA
    Melanoma Res; 1998 Apr; 8(2):149-55. PubMed ID: 9610868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of metastatic melanoma with chemotherapy and biologics.
    Atkins MB
    Curr Opin Oncol; 1997 Mar; 9(2):205-13. PubMed ID: 9161801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic melanoma: chemotherapy to biochemotherapy.
    O'Day SJ; Kim CJ; Reintgen DS
    Cancer Control; 2002; 9(1):31-8. PubMed ID: 11907464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient biochemotherapy with interleukin-2 and interferon alfa-2b in patients with metastatic malignant melanoma: results of two phase II cytokine working group trials.
    Flaherty LE; Atkins M; Sosman J; Weiss G; Clark JI; Margolin K; Dutcher J; Gordon MS; Lotze M; Mier J; Sorokin P; Fisher RI; Appel C; Du W
    J Clin Oncol; 2001 Jul; 19(13):3194-202. PubMed ID: 11432886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized phase III trial of biochemotherapy versus interferon-alpha-2b for adjuvant therapy in patients at high risk for melanoma recurrence.
    Kim KB; Legha SS; Gonzalez R; Anderson CM; Johnson MM; Liu P; Papadopoulos NE; Eton O; Plager C; Buzaid AC; Prieto VG; Hwu WJ; Frost AM; Alvarado G; Hwu P; Ross MI; Gershenwald JE; Lee JE; Mansfield PF; Benjamin RS; Bedikian AY
    Melanoma Res; 2009 Feb; 19(1):42-9. PubMed ID: 19430405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective study of biochemotherapy for metastatic melanoma: the importance of dose intensity.
    Minor DR; Madland MT; Kashani-Sabet M; Denny SR; Harvey WB
    Cancer Biother Radiopharm; 2005 Oct; 20(5):479-86. PubMed ID: 16248763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemotherapy for advanced melanoma.
    Buzaid AC
    Crit Rev Oncol Hematol; 2002 Oct; 44(1):103-8. PubMed ID: 12399002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of metastasized malignant melanoma].
    Kamanabrou D
    Praxis (Bern 1994); 2001 Mar; 90(10):391-6. PubMed ID: 11305184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II study of biochemotherapy for the treatment of metastatic malignant melanoma.
    Gibbs P; Iannucci A; Becker M; Allen J; O'Driscoll M; McDowell K; Williams P; Rosse P; Murphy J; Gonzalez R
    Melanoma Res; 2000 Apr; 10(2):171-9. PubMed ID: 10803718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.